Coronavirus disease and home recovery: a Singapore perspective.


Journal

Western Pacific surveillance and response journal : WPSAR
ISSN: 2094-7313
Titre abrégé: Western Pac Surveill Response J
Pays: Philippines
ID NLM: 101558993

Informations de publication

Date de publication:
2023
Historique:
medline: 17 11 2023
pubmed: 16 11 2023
entrez: 16 11 2023
Statut: epublish

Résumé

At the beginning of the coronavirus disease (COVID-19) pandemic in Singapore, the strategy initially involved aggressive ring-fencing of infections, before pivoting towards managing recurrent local interspersed outbreaks of COVID-19. A key feature of Singapore's efforts to preserve health-care capacity was the implementation of the nationwide Home Recovery Programme (HRP), whereby patients were allowed to recover at home as long as they met certain criteria. The programme was centrally coordinated by Singapore's Ministry of Health and was supported by telemedicine providers, primary care physicians and government agencies. This report aims to highlight Singapore's experience in coordinating and implementing the HRP, the challenges faced and the outcomes. Published and internal data from the Ministry of Health in Singapore, along with policy documents, were reviewed together with a brief literature review of similar programmes conducted globally. Implementation of the HRP led to the majority of patients (98%) recovering from COVID-19 in the outpatient setting, with similar mortality rates to inpatient settings. Hospitalization rates for COVID-19 cases were reduced as compared to previously, alleviating strain on the health-care system. The HRP was largely successful at preventing health-care capacities from being overwhelmed, while keeping fatalities to a minimum. Nonetheless, the risks of emergent variants of concern remain present, and heightened vigilance and potential modification of existing protocols based on fluctuations in virulence and infectivity are still needed.

Identifiants

pubmed: 37969814
doi: 10.5365/wpsar.2023.14.5.1003
pii: wpsar-14-1003
pmc: PMC10632601
doi:

Types de publication

Review Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-7

Informations de copyright

(c) 2023 The authors; licensee World Health Organization.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to declare.

Références

Nat Commun. 2022 Aug 8;13(1):4615
pubmed: 35941158
Lancet Reg Health West Pac. 2023 Jun;35:100719
pubmed: 37360873
Ann Intern Med. 2022 Nov;175(11):1622-1623
pubmed: 36095316
JAMA Netw Open. 2022 Aug 1;5(8):e2228900
pubmed: 36018588
J Med Syst. 2023 Jan 14;47(1):10
pubmed: 36640221
J Telemed Telecare. 2022 Aug 31;:1357633X221122890
pubmed: 36046925
JMIR Public Health Surveill. 2021 Apr 30;7(4):e25075
pubmed: 33667174
Clin Transl Immunology. 2022 Aug 23;11(8):e1403
pubmed: 36016852
BMJ Open. 2021 Sep 16;11(9):e042225
pubmed: 34531201

Auteurs

Hwee Yong Trevor Tan (HYT)

National Centre for Infectious Diseases, Singapore.

Joachim Wen Kien Yau (JWK)

Headquarters Medical Corps, Singapore Armed Forces, Ministry of Defence, Singapore.

Matthias Paul Han Sim Toh (MPHS)

National Public Health and Epidemiology Unit, National Centre for Infectious Diseases, Singapore.
Saw Swee Hock School of Public Health, National University of Singapore, Singapore.

Shawn Vasoo (S)

National Centre for Infectious Diseases, Singapore.
Infectious Disease Research Laboratory, National Centre for Infectious Diseases, Singapore.
Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.

Yee Sin Leo (YS)

National Centre for Infectious Diseases, Singapore.
Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH